Electrochemotherapy in Musculoskeletal Tumors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-08-01

Study Completion Date

2032-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study involves the enrollment of patients over 2 years of age with a diagnosis of musculoskeletal tumors and an indication for electrochemotherapy, treated at the Rizzoli Orthopaedic Institute in Bologna and followed during outpatient follow-up. Data will be collected from medical records, outpatient reports, and imaging studies including CT, X-ray, MRI, and/or PET.

For the retrospective part of the study, patients treated at the Rizzoli Orthopaedic Institute from 01/01/2024 to the date of approval of this study will be included. For the prospective part, patients meeting the inclusion criteria and treated from the study start date until 31/12/2030 will be enrolled.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Arterial Chemoembolization for the Treatment of Desmoid Fibromatosis

NCT06268457

Desmoid

RECRUITING

Malignant Myoepithelioma of Bone and Soft Tissues: Diagnostic Imaging and Histology in Relation to Prognosis

NCT06244420

Myoepithelioma

COMPLETED

Treatment of Desmoid Fibromatosis With Arterial Embolization

NCT06945887

Desmoid Fibromatosis

RECRUITING

Osteoarticular Tumor Characterization by Advanced Imaging

NCT02895633

Bone Tumor Soft Tissue Tumor

UNKNOWN NA

Giant Cell Tumor of the Extremities Treated With Surgery and/or Medical Treatment

NCT02996734

Giant Cell Tumor of Bone

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bone Tumors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients of both sexes with a histological diagnosis of a primary musculoskeletal tumor, either benign or malignant, located outside the abdominal cavity (trunk and limbs)
* Indication for electrochemotherapy due to one of the following conditions:

1. Clinical conditions contraindicating surgery
2. Tumor not surgically resectable
* Patients treated with electrochemotherapy at the Rizzoli Orthopaedic Institute:

1. From 01/01/2024 to the date of study approval for the retrospective phase
2. From the date of study approval to 12/31/2030 for the prospective phase
* Retrospectively treated patients with a minimum follow-up of at least 3 months
* Age ≥ 2 years at the time of treatment
* Availability of clinical and instrumental data

Minimum Eligible Age

2 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No